marginally significantp < 0.08
45%, p < 0.08, marginally significant) and chlamydia (72% vs. 45%, p < 0.09, marginally significant), being tested for a higher number of STIs (mean 3.75 vs. 3.04, p < 0.05), and offered triple anatomical site STI testing (54% vs. 18%, p < 0.001).